Management of HIV-associated focal brain lesions in developing countries

QJM. 2004 Jul;97(7):413-21. doi: 10.1093/qjmed/hch080.

Abstract

Background: HIV-associated focal brain lesions (HFBL) are caused by opportunistic infections, neoplasms, or cerebrovascular diseases. In developed countries, toxoplasma encephalitis (TE) is the most frequent cause, followed by primary CNS lymphoma (PCNSL). Guidelines based on these causes however are poorly suited to developing countries, where treatable infections predominate as causes of HFBL.

Aim: To determine a practical approach to the management of HFBL in developing countries.

Design: Case series.

Methods: Patients (n = 32) were managed based on presumed aetiologies of the focal brain lesions, determined by collating information from CT scans, CSF and blood studies, concurrent non-neurological illness and response to treatment.

Results: The principal presumed cause of HFBL was tuberculosis (69%). The therapeutic response was good in 69% of patients.

Discussion: In developing countries, infections are the predominant cause of HFBL, the principal causes being infections that are endemic to the populations being studied. Empiric treatment based on limited investigations should be directed according to the nature of such infections. A modified algorithm is proposed.

MeSH terms

  • AIDS-Related Opportunistic Infections / complications
  • AIDS-Related Opportunistic Infections / diagnostic imaging
  • AIDS-Related Opportunistic Infections / immunology
  • Adolescent
  • Adult
  • Algorithms
  • Antitubercular Agents / therapeutic use
  • Brain Diseases / complications*
  • Brain Diseases / immunology
  • Brain Diseases / virology
  • CD4 Lymphocyte Count
  • Developing Countries*
  • Female
  • HIV Infections / complications*
  • HIV Infections / immunology
  • HIV Infections / virology
  • HIV-1*
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • South Africa
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Tuberculosis, Central Nervous System / complications
  • Tuberculosis, Central Nervous System / diagnostic imaging
  • Tuberculosis, Central Nervous System / drug therapy
  • Viral Load

Substances

  • Antitubercular Agents